) The goal of this Phase II SBIR effort is to enable for the first time a complete capillary-based NMR detection solution for capillary LC (cLC). The primary benefit of capillary LC is enhanced separation efficiency. The primary benefit of microcoil NMR probe technology is enhanced mass sensitivity while simultaneously maintaining superior fluidics and chromatographic integrity. SBIR funding will enable the MRM team responsible for development of the first ever picomole sensitivity probe for high resolution NMR to develop a series of probes performance-optimized for cLC. This hyphenated technology combination has high potential for significantly impacting the fields of drug discovery, chemical products development, and other analytical-based industries.

Proposed Commercial Applications

Not Available

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
7R44RR014392-04
Application #
6952135
Study Section
Special Emphasis Panel (ZRG1-SSS-6 (01))
Program Officer
Swain, Amy L
Project Start
1999-09-01
Project End
2006-07-31
Budget Start
2005-09-30
Budget End
2006-07-31
Support Year
4
Fiscal Year
2002
Total Cost
$294,837
Indirect Cost
Name
Protasis Corporation
Department
Type
DUNS #
City
Marlboro
State
MA
Country
United States
Zip Code
01752
Jansma, Ariane; Chuan, Tiffany; Albrecht, Robert W et al. (2005) Automated microflow NMR: routine analysis of five-microliter samples. Anal Chem 77:6509-15